Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMET feasibility study
2013-003001-26Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Dec 2013
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Diprobase Cream and Doublebase Dayleve gel in atopic dermatitis (AD) (4 arms), sponsored by University of Bristol. Primary endpoint: Primary feasibility outcome. Started Dec 2013; status: completed.
02
Drugs
Diprobase CreamDoublebase Dayleve gel
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2013-003001-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003001-26.